Hyperpyrexia and prolonged postoperative disorientation following methylene blue infusion during parathyroidectomy

Anaesthesia

Volumn 61, Issue 6, 2006, Pages 580-583

  Mathew, S ^a   Linhartova, L ^a   Raghuraman, Govindan ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; ALUMINUM HYDROXIDE; ATORVASTATIN; ATRACURIUM; CALCIUM; CITALOPRAM; CLOPIDOGREL; DANTROLENE; FENTANYL; INSULIN; METHYLENE BLUE; NITROUS OXIDE; OMEPRAZOLE; PROPOFOL; QUININE SULFATE; REMIFENTANIL; SEVOFLURANE; SILDENAFIL; SODIUM CHLORIDE;

AGED; ANESTHESIA INDUCTION; ARTIFICIAL VENTILATION; CASE REPORT; CONSCIOUSNESS DISORDER; DIFFERENTIAL DIAGNOSIS; DISORIENTATION; DRUG INFUSION; ENDOTRACHEAL INTUBATION; EXTUBATION; GLASGOW COMA SCALE; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; HYPERPYREXIA; HYPERTENSION; HYPOCALCEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MALE; MALIGNANT HYPERTHERMIA; MEDICAL LITERATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; RESTLESSNESS; REVIEW; SHIVERING;

COLORING AGENTS; CONFUSION; FEMALE; FEVER; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; METHYLENE BLUE; MIDDLE AGED; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS;

EID: 33646699056     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2006.04619.x     Document Type: Review

References (12)

1. Anonymous. Drug Data Sheet. Mayne Pharma Pvt Ltd, Wellington 2004. http://www.medsafe.govt.nz/Profs/Datasheet/m/methyleneBlueinj.htm [accessed 22 July 2005].
2. Robert J, Delay D, Buhler L, Garcia A, Spilipoulos A. Methylene Blue in surgery for primary hyperparathyroidism. Annales d'Endocrinologie. 1998; 59: 23-6.
3. Bach KK, Lindsay FW, Berg LS, Howard RS. Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy. Anesthesia and Analgesia 2004; 99: 1573-4.
4. Martindale SJ, Stedeford JC. Neurological sequelae following methylene blue injection for parathyroidectomy. Anaesthesia 2003; 58: 1041-2.
5. Traynor S, Adams JR, Andersen P, Everts E, Cohen J. Appropriate timing and velocity of infusion for the selective staining of parathyroid glands by intravenous methylene blue. American Journal of Surgery 1998; 176: 15-7.
6. Peter C, Hongwan D, Kupfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. European Journal of Clinical Pharmacology 2000; 56: 247-50.
7. Faber P, Ronald A, Millar BW. Methylthionium chloride: Pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass. Anaesthesia 2005; 60: 575-87.
8. Nel A, Harvey BH. Haloperidol induced tardive dyskinesia is associated with striatal NO synthase suppression: Reversal with olanzipine. Behavioural Pharmacology 2003; 14: 251-5.
9. Guo X, Kedem J, Weiss H, Tse J, et al. Effect of cyclic GMP reduction on regional myocardial mechanics and metabolism in experimental left ventricular hypertrophy. Journal of Cardiovascular Pharmacology 1996; 27: 392-400.
10. Pfaffendorf M, Bruning TA, Batnik HD, Van Zwieten PA. Interaction between methylene blue and the cholinergic system. British Journal of Pharmacology 1997; 122: 95-8.
11. Inada H, Jinno S, Kohase H, Fukayama H, Umino M. Postoperative hyperthermia of unknown origin treated with dantrolene sodium. Anesthesia Progress 2005; 52: 21-3.
12. Araya V, Oviedo S, Amat J. Hungry bone syndrome: Clinical experience in its diagnosis and treatment. Revista Medica de Chile 2000; 128: 80-5.